Company / Book Value per Share
PharmaCyte Biotech, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.44
FY2025
5-year range
$3.44 / $4.658
FY2021-FY2025
Trend
-20.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from $0.004 in FY2020 to $4.658 in FY2021.
Based on SEC 10-K filings.
$3.44 in FY2025 with a 5-year CAGR of +281.6%.
Declined from $4.34 to $3.44 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -6.4%
- 5-Year CAGR
- +281.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +281.6%, indicating consistent growth.
- In FY2025, book value per share decreased 20.5% year-over-year.
- Peak book value per share was recorded in FY2021.
- Lowest book value per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.44 | -20.5% |
| FY2024 | $4.328 | -0.3% |
| FY2023 | $4.34 | +3.3% |
| FY2022 | $4.201 | -9.8% |
| FY2021 | $4.658 | +109530.7% |
| FY2020 | $0.004 | -25.4% |
| FY2019 | $0.006 | -36.3% |
| FY2018 | $0.009 | +7.0% |
| FY2017 | $0.008 | -21.3% |
| FY2016 | $0.011 | +421.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026